Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Pseudomonas quinolone signal receptor (PqsR), also known as the Multiple virulence factor regulator (MvfR), is a LysR-type transcriptional regulator that serves as a key component of the quorum-sensing network in the opportunistic pathogen Pseudomonas aeruginosa. PqsR is activated by binding to its native autoinducer ligands, 2-heptyl-3-hydroxy-4-quinolone (known as the Pseudomonas quinolone signal, or PQS) and its precursor 2-heptyl-4-quinolone (HHQ). Upon activation, PqsR binds to the promoter of the pqsABCDE operon, driving a positive feedback loop that amplifies the production of these signaling molecules and regulates the expression of numerous virulence factors, including pyocyanin, elastase, and lectins, as well as genes involved in biofilm formation and antibiotic tolerance.\n\nBecause PqsR controls pathogenicity traits without directly affecting bacterial viability, it has emerged as a highly attractive therapeutic target for pathoblocker or anti-virulence strategies. Inhibiting PqsR disrupts bacterial communication and biofilm development, thereby reducing virulence and potentially restoring the efficacy of conventional antibiotics against multi-drug resistant P. aeruginosa infections. Several small-molecule antagonists and inverse agonists, such as M64 and D88, are currently under preclinical development as adjunctive therapies to combat chronic and acute Pseudomonas infections.
Inhibition of the LysR-type transcriptional regulator PqsR to block quorum sensing signaling, reduce virulence factor production, and inhibit biofilm formation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudomonas quinolone signal receptor (PqsR).